13.25

2.40% 0.31

After Hours: 13.25

Cogent Biosciences Inc (COGT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Cogent Biosciences Inc stock is traded at $13.25, with a volume of 868.67K. It is up +2.40% in the last 24 hours and up +9.32% over the past month. Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Previous Close:

$12.94

Open:

$13.02

24h Volume:

868.67K

Relative Volume:

0.33

Market Cap:

$1.51B

Revenue:

Net Income/Loss:

$-284.08M

P/E Ratio:

-7.4438

EPS:

-1.78

Net Cash Flow:

$-234.65M

1W Performance:

+7.20%

1M Performance:

+9.32%

6M Performance:

+79.05%

1Y Performance:

+21.12%

1-Day Range:

$12.97

$13.55

1-Week Range:

$11.60

$13.55

52-Week Range:

$3.72

$13.55

Cogent Biosciences Inc Stock (COGT) Company Profile

Name

Cogent Biosciences Inc

Sector

Healthcare (1150)

Industry

Biotechnology (643)

Phone

617-945-5576

Address

275 WYMAN STREET, WALTHAM

Employee

205

Twitter

Next Earnings Date

2024-10-31

Latest SEC Filings

COGT's Discussions on Twitter

Compare COGT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
COGT Cogent Biosciences Inc	13.25	1.81B	0	-284.08M	-234.65M	-1.78
VRTX Vertex Pharmaceuticals Inc	376.62	97.36B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	576.98	60.19B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	458.37	59.56B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	729.76	44.94B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	329.84	36.14B	3.81B	-644.79M	-669.77M	-6.24

Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-03-25	Initiated	Raymond James	Strong Buy
Mar-07-25	Initiated	Scotiabank	Sector Outperform
Dec-11-24	Downgrade	Needham	Buy → Hold
Feb-26-24	Downgrade	Robert W. Baird	Outperform → Neutral
Feb-08-24	Initiated	Citigroup	Buy
Dec-11-23	Downgrade	Wedbush	Outperform → Neutral
Dec-08-23	Initiated	JP Morgan	Overweight
Apr-28-23	Initiated	Robert W. Baird	Outperform
Mar-27-23	Resumed	H.C. Wainwright	Buy
Dec-14-22	Initiated	Needham	Buy
Jun-28-22	Initiated	Guggenheim	Buy
Oct-11-21	Initiated	H.C. Wainwright	Buy
Jun-09-21	Resumed	Jefferies	Buy
Dec-23-20	Initiated	Piper Sandler	Overweight
Oct-14-20	Initiated	Ladenburg Thalmann	Buy

View All

Cogent Biosciences Inc Stock (COGT) Latest News

Sep 24, 2025

Cogent Biosciences stock hits 52-week high at 13.51 USD By Investing.com - Investing.com Canada

Sep 24, 2025

Cogent Biosciences (NASDAQ:COGT) Sets New 52-Week HighHere's What Happened - MarketBeat

Sep 24, 2025

Cogent Biosciences stock hits 52-week high at 13.51 USD - Investing.com

Sep 24, 2025

Is Cogent Biosciences Inc. building a consolidation baseJuly 2025 Snapshot & Reliable Intraday Trade Alerts - newser.com

Sep 24, 2025

Sep 23, 2025

Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $20.00 Average Target Price from Analysts - MarketBeat

Sep 23, 2025

How moving averages guide Cogent Biosciences Inc. tradingTrend Reversal & Capital Protection Trade Alerts - newser.com

Sep 23, 2025

Cogent Biosciences (NASDAQ:COGT) Shares Down 5.5%What's Next? - MarketBeat

Sep 23, 2025

Sep 22, 2025

Will Cogent Biosciences Inc. continue its uptrend2025 Risk Factors & AI Forecasted Entry and Exit Points - newser.com

Sep 22, 2025

When is the best time to exit Cogent Biosciences Inc.Quarterly Portfolio Report & Precise Entry and Exit Recommendations - newser.com

Sep 22, 2025

Is a relief rally coming for Cogent Biosciences Inc. holdersTrade Entry Report & Fast Moving Trade Plans - newser.com

Sep 22, 2025

Cogent Biosciences Inc. stock trend outlook and recovery pathJuly 2025 Volume & Fast Moving Market Watchlists - newser.com

Sep 22, 2025

Sep 21, 2025

Historical volatility pattern of Cogent Biosciences Inc. visualizedEarnings Summary Report & Expert Curated Trade Setup Alerts - newser.com

Sep 21, 2025

Aug Breakouts: What is the long term forecast for Cogent Biosciences Inc stock2025 Volume Leaders & High Accuracy Investment Signals - خودرو بانک

Sep 21, 2025